A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer

NCT02178956 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

714

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastric Cancer
Gastroesophageal Junction Cancer

Interventions

DRUG: BBI608
DRUG: Paclitaxel
OTHER: Placebo

Sponsor

Sumitomo Pharma America, Inc.